Literature DB >> 18802015

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients.

Erik S Stroes1, Melchior C Nierman, Janneke J Meulenberg, Remco Franssen, Jaap Twisk, C Pieter Henny, Mario M Maas, Aeilko H Zwinderman, Colin Ross, Eleonora Aronica, Katherine A High, Marcel M Levi, Michael R Hayden, John J Kastelein, Jan Albert Kuivenhoven.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802015     DOI: 10.1161/ATVBAHA.108.175620

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  81 in total

1.  Adeno-Associated Virus: The Naturally Occurring Virus Versus the Recombinant Vector.

Authors:  Arun Srivastava
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

Review 2.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

Review 3.  The AAV vector toolkit: poised at the clinical crossroads.

Authors:  Aravind Asokan; David V Schaffer; R Jude Samulski
Journal:  Mol Ther       Date:  2012-01-24       Impact factor: 11.454

4.  Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B.

Authors:  Valder R Arruda; Hansell H Stedman; Virginia Haurigot; George Buchlis; Stefano Baila; Patricia Favaro; Yifeng Chen; Helen G Franck; Shangzhen Zhou; J Fraser Wright; Linda B Couto; Haiyan Jiang; Glenn F Pierce; Dwight A Bellinger; Federico Mingozzi; Timothy C Nichols; Katherine A High
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

Review 5.  Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Nat Rev Genet       Date:  2011-05       Impact factor: 53.242

6.  AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

Authors:  Federico Mingozzi; Janneke J Meulenberg; Daniel J Hui; Etiena Basner-Tschakarjan; Nicole C Hasbrouck; Shyrie A Edmonson; Natalie A Hutnick; Michael R Betts; John J Kastelein; Erik S Stroes; Katherine A High
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

Review 7.  Plasma lipoproteins: genetic influences and clinical implications.

Authors:  Robert A Hegele
Journal:  Nat Rev Genet       Date:  2009-01-13       Impact factor: 53.242

Review 8.  Lessons learned from the clinical development and market authorization of Glybera.

Authors:  Laura M Bryant; Devin M Christopher; April R Giles; Christian Hinderer; Jesse L Rodriguez; Jenessa B Smith; Elizabeth A Traxler; Josh Tycko; Adam P Wojno; James M Wilson
Journal:  Hum Gene Ther Clin Dev       Date:  2013-06-29       Impact factor: 5.032

9.  Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.

Authors:  S A Hoyng; F De Winter; S Gnavi; L van Egmond; C L Attwell; M R Tannemaat; J Verhaagen; M J A Malessy
Journal:  Gene Ther       Date:  2015-05-04       Impact factor: 5.250

Review 10.  Genetic determinants of plasma triglycerides.

Authors:  Christopher T Johansen; Sekar Kathiresan; Robert A Hegele
Journal:  J Lipid Res       Date:  2010-11-01       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.